Increased ERCC Expression Correlates with Improved Outcome of Patients Treated with Cisplatin as an Adjuvant Therapy for Curatively Resected Gastric Cancer
Sun Kyung Baek, Si-Young Kim, Jae Jin Lee, Yoon Wha Kim, Hwi Joong Yoon, Kyung Sam Cho
Cancer Res Treat. 2006;38(1):19-24.   Published online 2006 Feb 28     DOI: https://doi.org/10.4143/crt.2006.38.1.19
Citations to this article as recorded by Crossref logo
Somatic mutation of DNAH genes implicated higher chemotherapy response rate in gastric adenocarcinoma patients
Chunchao Zhu, Qin Yang, Jia Xu, Wenyi Zhao, Zizhen Zhang, Danhua Xu, Yeqian Zhang, Enhao Zhao, Gang Zhao
Journal of Translational Medicine.2019;[Epub]     CrossRef
The design, analysis and application of mouse clinical trials in oncology drug development
Sheng Guo, Xiaoqian Jiang, Binchen Mao, Qi-Xiang Li
BMC Cancer.2019;[Epub]     CrossRef
Methods and significance of the combined detection of HER2 gene amplification and chemosensitivity in gastric cancer
Yang-Kun Wang, Su-Nan Wang, Ying-Ying Li, Gong-Ping Wang, Tian Yun, Chao-Ya Zhu, Bin-Feng Yang, Cong-Yang Li, Bo Jiang, Mei-Ling Zhu
Cancer Biomarkers.2018; 21(2): 439.     CrossRef
The Profile of Serum microRNAs Predicts Prognosis for Resected Gastric Cancer Patients Receiving Platinum-Based Chemotherapy
Jianning Song, Jie Yin, Zhigang Bai, Jun Zhang, Hua Meng, Jun Cai, Wei Deng, Xuemei Ma, Zhongtao Zhang
Digestive Diseases and Sciences.2017; 62(5): 1223.     CrossRef
Haplotype analysis on relationship of ERCC2 and ERCC3 gene polymorphisms with osteosarcoma risk in Chinese young population
Qiang Xu, Zuofu Zhang, Weixue Sun, Baiqiang Hu
Mammalian Genome.2017; 28(5-6): 227.     CrossRef
Prognostic value of excision repair cross-complementation group 1 expression in gastric cancer: A meta-analysis
PENG SONG, QIN YIN, MING LU, BO FU, BAOLIN WANG, QINGHONG ZHAO
Experimental and Therapeutic Medicine.2015; 9(4): 1393.     CrossRef
Predictive value of excision repair cross-complementation group 1 expression for platinum-based chemotherapy and survival in gastric cancer: a meta-analysis
Anqi Yao, You Wang, Xiaohong Peng, Rong Ye, Qiaoli Wang, Yuexiao Qi, Fuxiang Zhou
Journal of Cancer Research and Clinical Oncology.2014; 140(12): 2107.     CrossRef
Association between epidermal growth factor receptor gene copy number and ERCC1, BRCA1 protein expression in Chinese patients with non-small cell lung cancer
Yalei Zhang, Haihong Yang, Yuan Qiu, Qiuhua Deng, Jun Liu, Meiling Zhao, Ping He, Mingcong Mo, Xusen Zou, Jianxing He
Medical Oncology.2014;[Epub]     CrossRef
The prognostic value of ERCC1 expression in gastric cancer patients treated with platinum-based chemotherapy: a meta-analysis
Kong-Kong Wei, Lei Jiang, Yao-Yao Wei, Yu-Feng Wang, Xuan-Kun Qian, Qiang Dai, Quan-Lin Guan
Tumor Biology.2014; 35(9): 8721.     CrossRef
ERCC1 predicts outcome in patients with gastric cancer treated with adjuvant cisplatin-based chemotherapy
Sara De Dosso, Elena Zanellato, Martina Nucifora, Renzo Boldorini, Angelica Sonzogni, Roberto Biffi, Nicola Fazio, Eraldo Bucci, Ottavio Beretta, Stefano Crippa, Piercarlo Saletti, Milo Frattini
Cancer Chemotherapy and Pharmacology.2013; 72(1): 159.     CrossRef
Differential expression and prognostic value of ERCC1 and thymidylate synthase in resected gastric adenocarcinoma
Malcolm H. Squires, Sarah B. Fisher, Kevin E. Fisher, Sameer H. Patel, David A. Kooby, Bassel F. El‐Rayes, Charles A. Staley, Alton B. Farris, Shishir K. Maithel
Cancer.2013; 119(17): 3242.     CrossRef
GSTP1, ERCC1 and ERCC2 Polymorphisms, Expression and Clinical Outcome of Oxaliplatin-based Adjuvant Chemotherapy in Colorectal Cancer in Chinese Population
Hui-Yan Li, Xin Ge, Guang-Ming Huang, Kai-Yu Li, Jing-Quan Zhao, Xi-Miao Yu, Wen-Si Bi, Yu-Lin Wang
Asian Pacific Journal of Cancer Prevention.2012; 13(7): 3465.     CrossRef
Association of Four ERCC1 and ERCC2 SNPs with Survival of Bone Tumour Patients
Ting Hao, Wei Feng, Jie Zhang, Yong-Jian Sun, Gang Wang
Asian Pacific Journal of Cancer Prevention.2012; 13(8): 3821.     CrossRef
The Real Estate of Gastric Cancer Induction Therapy: Location Versus Intrinsic Molecular Architecture
Roderich E. Schwarz, John C. Mansour
Annals of Surgical Oncology.2012; 19(7): 2081.     CrossRef
Clinicopathologic significance of ERCC1, thymidylate synthase and glutathione S-transferase P1 expression for advanced gastric cancer patients receiving adjuvant 5-FU and cisplatin chemotherapy
Ki Han Kim, Hyuk-Chan Kwon, Sung Yong Oh, Sung Hyun Kim, Suee Lee, Kyung A Kwon, Jin Seok Jang, Min Chan Kim, Su-Jin Kim, Hyo-Jin Kim
Biomarkers.2011; 16(1): 74.     CrossRef
ERCC1: impact in multimodality treatment of upper gastrointestinal cancer
Ralf Metzger, Elfriede Bollschweiler, Arnulf H Hölscher, Ute Warnecke-Eberz
Future Oncology.2010; 6(11): 1735.     CrossRef
Biomarker analysis in stage III–IV (M0) gastric cancer patients who received curative surgery followed by adjuvant 5-fluorouracil and cisplatin chemotherapy: epidermal growth factor receptor (EGFR) associated with favourable survival
J-S Kim, M-A Kim, T M Kim, S-H Lee, D-W Kim, S-A Im, T-Y Kim, W H Kim, H-K Yang, D S Heo, Y-J Bang, K-U Lee, K-J Choe, N K Kim
British Journal of Cancer.2009; 100(5): 732.     CrossRef